The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine
Phase 4
196
about 4 years
8–18
1 site in MA
About this study
Researchers are testing a treatment called Adderall XR (mixed salts amphetamine) to see if it helps people with ADHD and autism. The trial will last 1461 days, involving brain imaging scans at MIT. Participants will take either Adderall XR or a placebo for 10 weeks, completing questionnaires and virtual visits.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Adderall XR (mixed salts amphetamine)
- 2.Take Placebo
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
stimulant (Amphetamine/dextroamphetamine (CNS stimulant combination)), NERVOUS SYSTEM
Secondary: Pre and post treatment changes in ASD core symptoms on Social Responsiveness Scale 2 (SRS-2)
Psychiatry / Mental Health